Immunology

Top Story

Pneumocystis prophylaxis may be unnecessary in autoimmune blistering diseases

September 11, 2017

One patient in a large cohort of individuals with autoimmune blistering diseases developed pneumocystis pneumonia, suggesting that routine prophylaxis of this condition may not be warranted in this patient population, according to recent findings.

The aim of the retrospective analysis was to shed further light on prophylaxis of pneumocystis pneumonia in immunocompromised patients who do not have HIV. Researchers investigated the incidence of this condition in a cohort of 801 patients with autoimmune blistering diseases who were receiving no prophylactic therapy.

In the Journals

Enanthemas commonly observed in non-classic pityriasis rosea

August 15, 2017
Enanthemas were commonly reported among patients with non-classic forms of pityriasis rosea, including persistent and pediatric forms of the disease. The retrospective…
In the Journals

Two histopathologic patterns found in cutaneous lupus of the scalp

August 14, 2017
Histopathologic assessment of hair follicles in patients with chronic cutaneous lupus erythematosus of the scalp revealed two distinct patterns, according to recent…

Phase 3 trial of Actemra for systemic sclerosis completes enrollment

August 11, 2017
This week, Genentech announced its phase 3 trial of Actemra for patients with systemic sclerosis has completed enrollment. The study will compare the drug’s safety…
More Headlines »
Advertisement
Advertisement